Track the 에스디바이오센서 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 에스디바이오센서 has published 12 insider filings. Market capitalisation: €716.5bn. The latest transaction was filed on 24 March 2026 (Purchase). Among the most active insiders: 조영식. All data is openly available.
12
Insider Decl.
n/a
Thresholds
€1m
11 ops.
Buy Volume
n/a
n/a
Sell Volume
13Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,307 of 29,063 companies
38.5
score / 100
Value
50
Quality
27
FCF yld39%
Earn yld-66%
EV/EBITDA·
ROE-18%
Gross mgn46%
Net mgn-72%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.